Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma

Dino Bekric; Maria Lina Tornesello; Matthias Ocker; Christian Mayr; Tobias Kiesslich; Daniel Neureiter

doi:10.3389/fcell.2023.1320084

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma

Front Cell Dev Biol. 2023 Nov 3:11:1320084. doi: 10.3389/fcell.2023.1320084. eCollection 2023.

Authors

Dino Bekric^{1

2}, Maria Lina Tornesello³, Matthias Ocker⁴, Christian Mayr¹, Tobias Kiesslich¹, Daniel Neureiter^{2

5}

Affiliations

¹ Center of Physiology, Pathophysiology and Biophysics, Institute of Physiology and Pathophysiology Salzburg, Paracelsus Medical University, Salzburg, Austria.
² Cancer Cluster Salzburg, Salzburg, Austria.
³ Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
⁴ Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Campus Charité Mitte, Charité University Medicine Berlin, Germany and Tacalyx GmbH, Berlin, Germany.
⁵ Institute of Pathology, University Clinics Salzburg, Paracelsus Medical University, Salzburg, Austria.

No abstract available

Keywords: biliary tract cancer; chemoresistance; hepatobiliary cancer; hepatocellular carcinoma; immunotherapy; therapeutic targets.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the PMU-FFF-stand-alone project (E-20/31/164-MAC).